Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs) Meeting Abstract


Authors: Johnson, S.; Johnson, N.; Chi, D.; Primack, B.; Cruz, C.; Stover, D.; Greifenberg, A. K.; Cao, S.; O'connor, K.; Baselga, J.; Balmana, J.; Serra, V.; Geyer, M.; D'Andrea, A.; Lim, E.; Shapiro, G. I.
Abstract Title: Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs)
Meeting Title: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 50
Issue: Suppl. 6
Meeting Dates: 2014 Nov 18-21
Meeting Location: Barcelona, Spain
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2014-11-01
Start Page: 80
Language: English
ACCESSION: WOS:000347755700239
PROVIDER: wos
DOI: 10.1016/S0959-8049(14)70364-8
Notes: Meeting Abstract: 238 -- 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 18-21, 2014 -- Barcelona, SPAIN -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga